Clinical Trial Update: Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD) [NA]

View source ↗

Summary

The clinical trial evaluating prazosin for neurophysiology and cognition in post-traumatic stress disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Prazosin (prazosin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Posttraumatic Stress Disorder | NA | Status: WITHDRAWN